The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in mice
Abstract
Several cytokines, in particular tumor necrosis factor‐α (TNF‐α) and interferon‐γ (IFN‐γ), have been shown to be responsible for pathological reactions which may lead to shock and death observed in infection with Gram‐negative bacteria and in response to endotoxins (lipopolysaccharides, LPS). Priming of mice with the avirulent Bacille Calmette Guérin (BCG) vaccine strain of Mycobacterium bovis increases the sensitivity of mice to the lethal effect of LPS and results in an efficient priming for cytokine production. In response to low doses (1 γg/mouse) of LPS, BCG‐primed mice produce interleukin‐12 (IL‐12) which controls IFN‐γ production, as demonstrated by the ability of neutralizing anti‐IL‐12 antibodies to suppress IFN‐γ production. However, the concentration of the biologically active IL‐12 p70 heterodimer is similar in the serum of both BCG‐primed or unprimed mice, reaching levels of 1–3 ng/ml at 3–6 h after LPS injection, whereas IFN‐γ production was observed only in BCG‐primed mice. The priming effect of BCG on IFN‐γ production appears to be mostly due to its ability to increase TNF‐α production, which acts as cofactor with LPS‐induced IL‐12 in inducing IFN‐γ production, as shown by the ability of injection of TNF‐α and LPS (1 γg/mouse), but not LPS alone, to induce IFN‐γ production. However, in addition to TNF‐α, other LPS‐induced cofactor(s) are required in cooperation with IL‐12 to induce optimal IFN‐γ production, because co‐injection of TNF‐α and IL‐12, sufficient to induce serum concentrations of both cytokines higher and more persistent than those obtained by injection of LPS, was not sufficient to induce IFN‐γ production in vivo. Neutralizing anti‐IL‐12 antibodies, in addition to inhibiting the in vivo LPS‐induced IFN‐γ production, also completely protect BCG‐primed mice injected with up to 10 μg of LPS from shock‐induced death. Thus, IL‐12 is required for IFN‐γ production and lethality in an endotoxic shock model in mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha
Doherty, G. M., Lange, J. R., Langstein, H. N., Alexander, H. R., Buresh, C. M., & Norton, J. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.5.1666 · Cited by 300
Cited by
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
Interleukin 15: biology and relevance to human disease
Fehniger, T. A., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.1.14 · Cited by 976
Interleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
Self-citationJordan, M. B., Hildeman, D., Kappler, J., & Marrack, P. (2004) · Blood · doi:10.1182/blood-2003-10-3413 · Cited by 712
Role of cytokines in endometriosis
Harada, T., Iwabe, T., & Terakawa, N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01816-7 · Cited by 567
Peyssonnaux, C., Cejudo-Martin, P., Doedens, A., Zinkernagel, A. S., Johnson, R. S., & Nizet, V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7516 · Cited by 480
Hammer, M., Mages, J., Dietrich, H., Servatius, A., Howells, N., Cato, A. C. B., & Lang, R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051753 · Cited by 327
Bachmann, M. F., Wong, B. R., Josien, R., Steinman, R. M., Oxenius, A., & Choi, Y. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1025 · Cited by 260
Carrillo‐Vico, A., Lardone, P. J., Naji, L., Fernández‐Santos, J. M., Martín‐Lacave, I., Guerrero, J. M., & Calvo, J. R. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00265.x · Cited by 204
Doolan, D. L., & Hoffman, S. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.884 · Cited by 183
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., Gatewood, S. J. L., & Rose, N. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.261 · Cited by 133
IL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice
Salkowski, C. A., Kopydlowski, K., Blanco, J., Cody, M. J., McNally, R., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1529 · Cited by 119
STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia
Lentsch, A. B., Kato, A., Davis, B., Wang, W., Chao, C., & Edwards, M. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113763 · Cited by 63
Trinchieri, G. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470514849.ch14 · Cited by 23
Self-citation
Metadata
- Authors
- Wysocka, M., Kubin, M., Vieira, L. Q., Ozmen, L., Garotta, G., Scott, P., & Trinchieri, G.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1995-03
- Volume
- 25
- Issue
- 3
- Pages
- 672-676
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2062922499
- Cited by
- 467
- References
- 3
- FWCI
- 17.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.